Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,731 | 5,353 | 3,435 | 2,504 | 5,805 |
| Marketable Securities | 47,540 | 60,590 | 68,320 | 73,399 | 73,895 |
| Receivables | 1,812 | 1,712 | 1,036 | 1,939 | 2,121 |
| TOTAL | $64,083 | $67,655 | $72,791 | $77,842 | $81,821 |
| Non-Current Assets | |||||
| PPE Net | 3,986 | 4,375 | 4,792 | 5,248 | 5,611 |
| Investments And Advances | 21 | 19 | 19 | 15 | 14 |
| TOTAL | $4,007 | $4,394 | $4,811 | $5,263 | $5,625 |
| Total Assets | $68,090 | $72,049 | $77,602 | $83,105 | $87,446 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,477 | 3,253 | 4,044 | 3,574 | 3,449 |
| Other current liabilities | 676 | 712 | 104 | 81 | 103 |
| TOTAL | $4,946 | $4,652 | $4,664 | $4,661 | $4,633 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 793 | 687 | 516 | 1,006 | 1,081 |
| Other Non-Current Liabilities | 3,123 | 2,962 | 3,471 | 3,335 | 3,448 |
| TOTAL | $3,191 | $3,050 | $3,560 | $3,439 | $3,478 |
| Total Liabilities | $8,137 | $7,702 | $8,224 | $8,100 | $8,111 |
| Shareholders' Equity | |||||
| Common Shares | 142 | 142 | 142 | 142 | 142 |
| Retained earnings | -127,187 | -122,418 | -117,032 | -110,808 | -105,784 |
| TOTAL | $59,953 | $64,347 | $69,378 | $75,005 | $79,335 |
| Total Liabilities And Equity | $68,090 | $72,049 | $77,602 | $83,105 | $87,446 |